Table 2.
Changes in AD drug prescribing pre‐ and post‐PrecivityAD blood testing.
APS category | AD drug use | p‐value | Relative change from usual care | |
---|---|---|---|---|
Pre | Post | |||
Low (n = 133) | 64 (48%) | 34 (26%) | <0.0001 | 46% decrease |
Intermediate (n = 52) | 26 (50%) | 21 (40%) | 0.431 | 20% decrease |
High (n = 162) | 91 (56%) | 142 (88%) | <0.0001 | 57% increase |
Overall | 181 (52%) | 197 (57%) | 0.253 | 10% increase |